Literature DB >> 3593435

Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus.

A Mackiewicz, R Marcinkowska-Pieta, S Ballou, S Mackiewicz, I Kushner.   

Abstract

We evaluated the clinical usefulness of determinations of alpha 1-acid glycoprotein microheterogeneity patterns in distinguishing patients who have active systemic lupus erythematosus (SLE) from those who have SLE with intercurrent infection. We used agarose affinity electrophoresis with concanavalin A (Con A) as a ligand. Results were expressed as reactivity coefficients (RC), which are the ratios of variants reactive with Con A to the variants not reactive with Con A. No significant differences were found between the mean RC (+/- SD) in healthy individuals (1.35 +/- 0.26) and that in patients with various degrees of SLE activity. In contrast, a significantly higher mean RC was found in sera from patients with intercurrent infection (2.70 +/- 0.76) compared with each of the other groups studied (P less than 0.001). An RC greater than 2.25 was found in none of 42 sera from patients without infection and in 15 of 18 sera from patients with infection (sensitivity 83%, specificity 100%). C-reactive protein (CRP) levels were also significantly higher in SLE patients with intercurrent infection than in patients with very active disease (P less than 0.05). Levels of CRP greater than 60 mg/liter were found in 3 of 42 SLE patients without infection and in 8 of 18 patients with infection (sensitivity 39%, specificity 93%). The results show that in SLE patients, the finding of a relative increase in Con A-bound serum alpha 1-acid glycoprotein is a more sensitive indicator of intercurrent infection than is the finding of increased levels of CRP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593435     DOI: 10.1002/art.1780300505

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

2.  Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.

Authors:  W van Dijk; O Pos; M E van der Stelt; H J Moshage; S H Yap; L Dente; P Baumann; C B Eap
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

3.  Comparison of microheterogeneity of alpha-1-acid-glycoprotein in serum and synovial fluid from rheumatoid arthritis patients.

Authors:  J K Lacki; K Klama; W Samborski; S H Mackiewicz; W Muller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

4.  Development of a microcolumn one-site immunometric assay for a protein biomarker: Analysis of alpha1-acid glycoprotein.

Authors:  Chenhua Zhang; Shae Lott; William Clarke; David S Hage
Journal:  J Chromatogr A       Date:  2019-09-20       Impact factor: 4.759

5.  Glycoform analysis of alpha1-acid glycoprotein based on capillary electrophoresis and electrophoretic injection.

Authors:  Chenhua Zhang; Cong Bi; William Clarke; David S Hage
Journal:  J Chromatogr A       Date:  2017-08-15       Impact factor: 4.759

6.  Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.

Authors:  A Mackiewicz; D Schultz; J Mathison; M Ganapathi; I Kushner
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis.

Authors:  A Mackiewicz; M A Khan; T L Reynolds; S van der Linden; I Kushner
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

8.  Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

9.  Abnormal glycosylation of alpha 2-macroglobulin, a non-acute-phase protein in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; A Guglielmotti; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

10.  Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment?

Authors:  J Braun; F Sörgel; W P Gluth; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.